Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 27, 2003 02:29 ET | Source: Crucell N.V.

Crucell Reports 2002 Annual Results

LEIDEN, The Netherlands, Jan. 27, 2003 (PRIMEZONE) -- Crucell N.V. (Nasdaq:CRXL) today announced its 2002 financial results. Total revenues for the year ended December 31, 2002 are $9.6 million...
January 16, 2003 02:14 ET | Source: Crucell N.V.

Crucell Signs PER.C6 Antibody Production Agreement with Centocor

LEIDEN, The Netherlands, Jan. 16, 2003 (PRIMEZONE) -- Dutch antibody and vaccine company Crucell N.V. (Nasdaq:CRXL) today announced that it has signed a PER.C6(TM) research license agreement with...
December 24, 2002 02:40 ET | Source: Crucell N.V.

Centocor Returns Rights to Anti-CD46 Antibody to Crucell

LEIDEN, The Netherlands, Dec. 24, 2002 (PRIMEZONE) -- Dutch antibody and vaccine company, Crucell N.V. (Nasdaq:CRXL) today announced that Centocor and Crucell have agreed not to advance the...
December 23, 2002 03:24 ET | Source: Crucell N.V.

Crucell Expects Charge Related to Impairment of Goodwill

LEIDEN, The Netherlands, Dec. 23, 2002 (PRIMEZONE) -- Dutch antibody and vaccine company, Crucell N.V. (Nasdaq:CRXL) today announced that it expects to record a goodwill impairment charge during the...
December 20, 2002 02:33 ET | Source: Crucell N.V.

Cambridge Antibody Technology and Crucell Settle Patent Dispute

MELBOURN, U.K. and LEIDEN, The Netherlands, Dec. 20, 2002 (PRIMEZONE) -- Cambridge Antibody Technology (LSE:CAT) (Nasdaq:CATG) and Crucell N.V. (Nasdaq: CRXL) today announced that they have agreed on...
October 04, 2002 11:07 ET | Source: Crucell N.V.

Crucell NV: Invitation Conference Call Q3 Results 2002

LEIDEN, The Netherlands, Oct. 4, 2002 (PRIMEZONE) -- Crucell NV conference call information: Monday October 14, 2002 at 15:00 Central European Time 14.00 London...
November 14, 2001 07:48 ET | Source: Crucell N.V.

Galapagos Genomics and Pharmacia Enter Three-Year Gene Target Identification Collaboration

MECHELEN, Belgium, Nov. 14, 2001 (PRIMEZONE) -- Galapagos Genomics NV, the Belgian functional genomics company, today announced that it has entered into a broad functional genomics collaboration with...
October 22, 2001 08:51 ET | Source: Crucell N.V.

Galapagos Genomics and Procter & Gamble Pharmaceuticals Announce Functional Genomics Collaboration

MECHELEN, Belgium, and CINCINNATI, Oh., USA, Oct. 22, 2001 (PRIMEZONE) -- Galapagos Genomics NV, the Belgian functional genomics company, and Procter & Gamble Pharmaceuticals (P&GP), a...